A Single Dose, Open-label, One Sequence, 2-period, Crossover Study to Characterize the Pharmacokinetics and Pharmacodynamics of Ticagrelor and Prasugrel in Healthy Male Adult Subjects
Phase of Trial: Phase I
Latest Information Update: 16 Feb 2015
Price : $35 *
At a glance
- Drugs Prasugrel (Primary) ; Ticagrelor (Primary)
- Indications Acute coronary syndromes; Coronary artery disease; Embolism and thrombosis; Peripheral arterial disorders; Sickle cell anaemia; Stroke
- Focus Pharmacodynamics
- 11 Jul 2013 Planned End Date 1 Aug 2013 added as reported by ClinicalTrials.gov.
- 11 Jul 2013 Planned initiation date 1 Jul 2013 added as reported by ClinicalTrials.gov.
- 03 Jul 2013 New trial record